PepGen Inc trading halted, volatility trading pause
PremiumThe FlyPepGen Inc trading halted, volatility trading pause
2M ago
PepGen Reports Progress in Duchenne Treatment Trials
Premium
Company Announcements
PepGen Reports Progress in Duchenne Treatment Trials
2M ago
PepGen reports ‘positive’ data from low-dose cohort of PGN-EDO51
Premium
The Fly
PepGen reports ‘positive’ data from low-dose cohort of PGN-EDO51
2M ago
XLP ETF: Invest in Consumer Staples Stocks with Durable Demand 
PremiumMarket NewsXLP ETF: Invest in Consumer Staples Stocks with Durable Demand 
5M ago
PepGen to Participate in Upcoming Investor Conferences
Premium
Press Releases
PepGen to Participate in Upcoming Investor Conferences
6M ago
PepGen receives Orphan Drug, Rare Pediatric Disease designations for PGN-EDO51
Premium
The Fly
PepGen receives Orphan Drug, Rare Pediatric Disease designations for PGN-EDO51
6M ago
PepGen price target lowered to $20 from $21 at Wedbush
PremiumThe FlyPepGen price target lowered to $20 from $21 at Wedbush
7M ago
PepGen Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments
Premium
Press Releases
PepGen Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments
7M ago
PepGen announces clearance of CTA by U.K. MHRA to begin CONNECT2-EDO51
Premium
The Fly
PepGen announces clearance of CTA by U.K. MHRA to begin CONNECT2-EDO51
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100